Cargando…
Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A
Clostridium perfringens is a spore-forming, Gram-positive anaerobic pathogen that causes several disorders in humans and animals. A multidrug-resistant Clostridium strain was isolated from the fecal sample of a patient who was clinically suspected of gastrointestinal infection and had a recent histo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302382/ https://www.ncbi.nlm.nih.gov/pubmed/37368661 http://dx.doi.org/10.3390/toxins15060359 |
_version_ | 1785065033357590528 |
---|---|
author | AlJindan, Reem AlEraky, Doaa M. Farhat, Maha Almandil, Noor B. AbdulAzeez, Sayed Borgio, Jesu Francis |
author_facet | AlJindan, Reem AlEraky, Doaa M. Farhat, Maha Almandil, Noor B. AbdulAzeez, Sayed Borgio, Jesu Francis |
author_sort | AlJindan, Reem |
collection | PubMed |
description | Clostridium perfringens is a spore-forming, Gram-positive anaerobic pathogen that causes several disorders in humans and animals. A multidrug-resistant Clostridium strain was isolated from the fecal sample of a patient who was clinically suspected of gastrointestinal infection and had a recent history of antibiotic exposure and diarrhea. The strain was identified by 16s rRNA sequencing as Clostridium perfringens. The strain’s pathogenesis was analyzed through its complete genome, specifically antimicrobial resistance-related genes. The Clostridium perfringens IRMC2505A genome contains 19 (Alr, Ddl, dxr, EF-G, EF-Tu, folA, Dfr, folP, gyrA, gyrB, Iso-tRNA, kasA, MurA, rho, rpoB, rpoC, S10p, and S12p) antibiotic-susceptible genetic species according to the k-mer-based detection of antimicrobial resistance genes. Genome mapping using CARD and VFDB databases revealed significant (p-value = 1 × 10(−26)) genes with aligned reads against antibiotic-resistant genes or virulence factors, including phospholipase C, perfringolysin O, collagenase, hyaluronidase, alpha-clostripain, exo-alpha-sialidase, and sialidase activity. In conclusion, this is the first report on C. perfringens from Saudi Arabia that conducted whole genome sequencing of IRMC2505A and confirmed the strain as an MDR bacterium with several virulence factors. Developing control strategies requires a detailed understanding of the epidemiology of C. perfringens, its virulence factors, and regional antimicrobial resistance patterns. |
format | Online Article Text |
id | pubmed-10302382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103023822023-06-29 Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A AlJindan, Reem AlEraky, Doaa M. Farhat, Maha Almandil, Noor B. AbdulAzeez, Sayed Borgio, Jesu Francis Toxins (Basel) Article Clostridium perfringens is a spore-forming, Gram-positive anaerobic pathogen that causes several disorders in humans and animals. A multidrug-resistant Clostridium strain was isolated from the fecal sample of a patient who was clinically suspected of gastrointestinal infection and had a recent history of antibiotic exposure and diarrhea. The strain was identified by 16s rRNA sequencing as Clostridium perfringens. The strain’s pathogenesis was analyzed through its complete genome, specifically antimicrobial resistance-related genes. The Clostridium perfringens IRMC2505A genome contains 19 (Alr, Ddl, dxr, EF-G, EF-Tu, folA, Dfr, folP, gyrA, gyrB, Iso-tRNA, kasA, MurA, rho, rpoB, rpoC, S10p, and S12p) antibiotic-susceptible genetic species according to the k-mer-based detection of antimicrobial resistance genes. Genome mapping using CARD and VFDB databases revealed significant (p-value = 1 × 10(−26)) genes with aligned reads against antibiotic-resistant genes or virulence factors, including phospholipase C, perfringolysin O, collagenase, hyaluronidase, alpha-clostripain, exo-alpha-sialidase, and sialidase activity. In conclusion, this is the first report on C. perfringens from Saudi Arabia that conducted whole genome sequencing of IRMC2505A and confirmed the strain as an MDR bacterium with several virulence factors. Developing control strategies requires a detailed understanding of the epidemiology of C. perfringens, its virulence factors, and regional antimicrobial resistance patterns. MDPI 2023-05-25 /pmc/articles/PMC10302382/ /pubmed/37368661 http://dx.doi.org/10.3390/toxins15060359 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article AlJindan, Reem AlEraky, Doaa M. Farhat, Maha Almandil, Noor B. AbdulAzeez, Sayed Borgio, Jesu Francis Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A |
title | Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A |
title_full | Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A |
title_fullStr | Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A |
title_full_unstemmed | Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A |
title_short | Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A |
title_sort | genomic insights into virulence factors and multi-drug resistance in clostridium perfringens irmc2505a |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302382/ https://www.ncbi.nlm.nih.gov/pubmed/37368661 http://dx.doi.org/10.3390/toxins15060359 |
work_keys_str_mv | AT aljindanreem genomicinsightsintovirulencefactorsandmultidrugresistanceinclostridiumperfringensirmc2505a AT alerakydoaam genomicinsightsintovirulencefactorsandmultidrugresistanceinclostridiumperfringensirmc2505a AT farhatmaha genomicinsightsintovirulencefactorsandmultidrugresistanceinclostridiumperfringensirmc2505a AT almandilnoorb genomicinsightsintovirulencefactorsandmultidrugresistanceinclostridiumperfringensirmc2505a AT abdulazeezsayed genomicinsightsintovirulencefactorsandmultidrugresistanceinclostridiumperfringensirmc2505a AT borgiojesufrancis genomicinsightsintovirulencefactorsandmultidrugresistanceinclostridiumperfringensirmc2505a |